TIAA Trust, National Association
ELDN icon

TIAA Trust, National Association’s Eledon Pharmaceuticals ELDN Stock Holding History

TIAA Trust, National Association’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,000
Closed -$28.7K – 468
2025
Q4 		$28.7K Buy
+19,000
New +$45.2K ﹤0.01% 678

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

TIAA Trust, National Association's ELDN Position: Q1 2026 in Review

TIAA Trust, National Association sold out of Eledon Pharmaceuticals (ELDN) in Q1 2026, closing a stake of 19,000 shares — an estimated $28.7K sold.

TIAA Trust, National Association first reported a position in ELDN in Q4 2025 and held it in 1 quarter. The position peaked at $28.7K in Q4 2025. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • TIAA Trust, National Association reported no remaining Eledon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 19,000 Eledon Pharmaceuticals shares in Q1 2026, an estimated $28.7K.
  • TIAA Trust, National Association first reported a position in Eledon Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • TIAA Trust, National Association's Eledon Pharmaceuticals position peaked at $28.7K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.